PANGAEA Oncology Logo

PANGAEA Oncology

Precision oncology services in diagnostics and R&D for patients and the pharmaceutical industry.

PANG | BME Growth

Overview

Corporate Details

ISIN(s):
ES0105221008
LEI:
959800TSRNQZYHX37Y29
Country:
Spain
Address:
C/ COSO 42 4º, 50004 Zaragoza
Sector:
Human health and social work activities
Industry:
Other human health activities

Description

PANGAEA Oncology is a medical services company specializing in precision oncology, dedicated to improving the survival and quality of life for cancer patients. Founded in 2007, the company provides services to both patients and the pharmaceutical industry. Its offerings include advanced molecular diagnostics, validation for companion diagnostic (Dx) platforms, and a range of preclinical R&D services such as biomarker discovery, in-vitro testing, and organoid technology. A key innovator, PANGAEA was the first laboratory in Spain to be accredited for liquid biopsy techniques. By operating directly within hospital settings, the company accelerates clinical trials by providing direct access to patients, samples, and clinical data, positioning itself as a leading recruitment center. PANGAEA leverages genetic analyses and data-driven approaches to advance personalized cancer treatment and research.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for PANGAEA Oncology and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PANGAEA Oncology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PANGAEA Oncology via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Center for Genetics and Reproductive Medicine "GENETICO" Logo
Advanced genetic testing for reproductive health, prenatal screening, and oncogenetics.
Russian Federation GECO
Debarski Banji Capa AD Logo
Offers medical rehab and spa wellness using unique thermo-mineral waters.
North Macedonia DEBA
Diagnostyka SA Logo
Poland's largest medical lab network offering over 4,000 routine and specialist diagnostic tests.
Poland DIAG
Develops digital diagnostic tests for healthcare pros, enabling personalized disease treatment.
United Kingdom N/A
Genomed Spolka Akcyjna Logo
Offers molecular diagnostics and DNA sequencing for medical and scientific research markets.
Poland GEN
iDNA Genomics Public Ltd Logo
Provides AI-driven DNA tests for personalized health, wellness, and medication insights.
Cyprus IDNA
Imalliance Logo
A French medical imaging network offering radiology, MRI, and scans to patients and professionals.
France MLIML
IMCB PJSC Logo
Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.
Russian Federation GEMA
Immunovia Logo
Develops blood tests for early pancreatic cancer detection in high-risk individuals.
Sweden IMMNOV
Inify Laboratories AB Logo
AI-powered digital pathology lab providing fast cancer diagnostics for healthcare providers.
Sweden INIFY

Talk to a Data Expert

Have a question? We'll get back to you promptly.